Treatment outcomes with purine nucleoside analog alone or with rituximab for hairy cell leukemia at first relapse.
Saved in:
| Title: | Treatment outcomes with purine nucleoside analog alone or with rituximab for hairy cell leukemia at first relapse. |
|---|---|
| Authors: | Hu, Rachel1 (AUTHOR), Wei, Wei1 (AUTHOR), Mian, Agrima1 (AUTHOR), Gonter‐Aubin, Kristen2 (AUTHOR), Kabel, Charlene3 (AUTHOR), Mato, Anthony3 (AUTHOR), Stephens, Deborah M.4 (AUTHOR), Hanlon, Ashley5 (AUTHOR), Khajavian, Sirin6 (AUTHOR), Shadman, Mazyar6 (AUTHOR), Brander, Danielle5 (AUTHOR), Madanat, Yazan1 (AUTHOR), Park, Jae H.3 (AUTHOR), Tallman, Martin3 (AUTHOR), Pinilla‐Ibarz, Javier2 (AUTHOR), Hill, Brian T.1 (AUTHOR) hillb2@ccf.org |
| Source: | European Journal of Haematology. May2022, Vol. 108 Issue 5, p379-382. 4p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
